T1	condition 14 35	acute radiodermatitis
T2	intervention 39 57	photobiomodulation
T3	No-of-participants 513 516	120
T4	eligibility 517 583	BC patients that underwent an identical RT regimen post-lumpectomy
T5	intervention 339 372	photobiomodulation therapy (PBMT)
T6	control 646 653	placebo
T7	intervention-participants 666 668	60
T8	control-participants 666 668	60
T9	outcome-Measure 985 999	Skin reactions
T10	outcome-Measure 1218 1233	quality of life
T11	outcome 1504 1534	severity of the skin reactions
T12	outcome 1644 1666	RTOG grade 2 or higher
T13	control-value 1716 1719	30%
T14	intervention-value 1724 1728	6.7%
T15	outcome 1911 1926	quality of life
